Sunday - December 4, 2022
Amicus Therapeutics Assigned Patent for Methods of Treating Fabry Patients Having Renal Impairment
Copyright © Targeted News Service, 2022
ALEXANDRIA, Va., July 8 -- Amicus Therapeutics, Philadelphia, Pennsylvania, has been assigned a patent (No. 11,376,244, initially filed Feb. 11, 2022) developed by two co-inventors for "methods of treating Fabry patients having renal impairment." The co-inventors are Jeff Castelli, New Hope, Pennsylvania, and Elfrida Benjamin, Millstone Township, New Jersey.

The full-text of the patent can be found at . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

What's your
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information or a free trial

Copyright Targeted News Service 2022